DR. Brocks, F. Jamali, Etodolac clinical pharmacokinetics., in Clin Pharmacokinet, vol. 26, n. 4, Apr 1994, pp. 259-74, PMID8013160.
LZ. Benet, Pharmacokinetic profile of etodolac in special populations., in Eur J Rheumatol Inflamm, vol. 14, n. 1, 1994, pp. 15-8, PMID7744123.
N. Zvaifler, A review of the antiarthritic efficacy and safety of etodolac., in Clin Rheumatol, 8 Suppl 1, Mar 1989, pp. 43-53, PMID2525982.
DH. Neustadt, Double blind evaluation of the long-term effects of etodolac versus ibuprofen in patients with rheumatoid arthritis., in J Rheumatol Suppl, vol. 47, Feb 1997, pp. 17-22, PMID9035016.
G. Spencer-Green, Low dose etodolac in rheumatoid arthritis: a review of early studies., in J Rheumatol Suppl, vol. 47, Feb 1997, pp. 3-9; discussion 48-50, PMID9035014.
EM. Veys, Clinical performance of etodolac in patients with osteoarthritis and rheumatoid arthritis., in Eur J Rheumatol Inflamm, vol. 14, n. 1, 1994, pp. 23-7, PMID7744125.
TJ. Schnitzer, G. Constantine, Etodolac (Lodine) in the treatment of osteoarthritis: recent studies., in J Rheumatol Suppl, vol. 47, Feb 1997, pp. 23-31, PMID9035017.
TJ. Schnitzer, IM. Ballard; G. Constantine; P. McDonald, Double-blind, placebo-controlled comparison of the safety and efficacy of orally administered etodolac and nabumetone in patients with active osteoarthritis of the knee., in Clin Ther, vol. 17, n. 4, pp. 602-12, PMID8565024.
CL. Benhamou, JL. Feldmann; R. Dropsy, [Efficacy, tolerability and therapeutic benefit of etodolac (Lodine 200) in rheumatologic practice]., in Rev Med Interne, vol. 10, n. 2, Mar 1989, pp. 163-73, PMID2525800.
CL. Benhamou, Large-scale open trials with etodolac (Lodine) in France: an assessment of safety., in Rheumatol Int, 10 Suppl, 1990, pp. 29-34, PMID2150569.
JA. Balfour, MM. Buckley, Etodolac. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain states., in Drugs, vol. 42, n. 2, Aug 1991, pp. 274-99, PMID1717225.